Rebecca H. Clayman

Suggest Changes
Learn More
BACKGROUND Tri-modality therapy (TMT) is a recognized treatment strategy for selected patients with muscle-invasive bladder cancer (MIBC). OBJECTIVE Report long-term outcomes of patients with MIBC(More)
PURPOSE We describe the incidence, clinicopathological risk factors, management and outcomes of recurrent nonmuscle invasive bladder cancer after a complete response to trimodality therapy of muscle(More)